| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.5 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |